Michael Tully

Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York.

Polaris Partners is an Independent Venture Capital firm founded in 1996 by Stephen D. Arnold, Jonathan A. Flint and Terrance G. McGuire. Polaris Partners is headquartered in Waltham.

Part of Unicharm Corp., Pet Products, Inc. is a company that makes pet products, specifically bones. The company is based in Yonkers, NY. Pet Products was acquired by The Hartz Mountain Corp., part of Unicharm Corp. from December 30, 2011 on March 02, 1995 for $15.48 million.

DLA Piper LLP provides legal services to clients. It offers services in the areas of corporate and securities, venture capital and emerging companies, litigation. The company was founded in 2005 and it is headquartered in Baltimore, MD.

Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA.

The Mount Sinai Hospital provides medical and healthcare services. The company was founded in 1952 and is headquartered in New York, NY.

Action Against Hunger-USA is a non-profit organization, which engages in the provision of access to safe water and sustainable solutions to hunger. Its programs include nutrition and health, water, sanitation, and hygiene, food security and livelihoods, and emergency response. The company was founded by Burton K. Haimes in 1985 and is headquartered in New York, NY.

Pfizer Nutrition develops nutritional products such as baby formula, for infants, young children, and pregnant mothers. The company is headquartered in Madison, NJ.

Kallyope, Inc. engages in developing drugs and consumer products. Its specialties include biotechnology, gut-brain axis, nutrition, and pharmaceuticals. The company was founded by Thomas P. Maniatis, Charles Zuker and Richard Axel in 2014 and is headquartered in New York, NY.

Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA.

Olivo Laboratories LLC provides solutions to skin-related medical problems through proprietary biomaterials technologies. Its platform technology consists of a tunable polysiloxane-based material that mimics youthful skin and can be engineered to provide a variety of targeted properties, including elasticity, breathability, invisibility, water resistance, protection. The company was founded by Robert S. Langer Jr. and Richard Rox Anderson and is headquartered in Cambridge, MA.

Quentis Therapeutics, Inc. operates as a biotechnology company. It develops therapeutics in the onco-immunology field. The company was founded by Juan R. cubillos-Ruiz and is headquartered in New York, NY.

Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA.

Thirty Madison, Inc. provides personal care products. It offers non-medicated hair care and scalp care preparations for men. The company was founded by Steven Craig Gutentag and Demetrius Michael Karagas and is headquartered in New York, NY.

Suono Bio, Inc. develops therapeutics to the gastrointestinal tract which helps to cure diseases. The company was founded by Carl Schoellhammer, Robert S. Langer Jr., Amy W. Schulman, and Giovanni Traverso and is headquartered in Cambridge, MA.

VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts.

Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA.

Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA.

105 W First Street LLC engages in real estate industry. The company was founded in 2019 and is headquartered in New York, NY.

Candesant Biomedical, Inc. engages in the provision of healthcare medical services. It focuses on development of a novel treatment for the non-invasive treatment of excessive sweating or hyperhidrosis. The company was founded by Niquette Hunt and Jacob Waugh and is headquartered in San Francisco, CA.

Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA.

Amagma, Inc. provides healthcare services. The company is headquartered in Waltham, MA.

Breakthrough Properties LLC engages in the provision of real estate development services. It offers best-in-class physical infrastructure, user-driven perspective, and mentorship. The company was founded by Dan Belldegrun and is headquartered in Los Angeles, CA.

Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022.

Part of Breakthrough Properties LLC, Breakthrough Properties Growth Portfolio I LP functions as a pooled investment and private equity fund. The company is based in Los Angeles, CA.

IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish.

Part of Breakthrough Properties LLC, D3C1 Allston Co-Investment LP functions as an investment fund. The company is based in Los Angeles, CA.

76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation.

Larkspur Biosciences, Inc. is a company based in Watertown, MA that is pioneering a new wave in cancer therapy. Larkspur’s approach targets cancer-intrinsic factors that tumors use to escape immune detection and control to develop new treatment options for patients who cannot be helped by current therapies. The company is advancing first-in-class programs designed to eliminate tumor “bottlenecks” that drive immune evasion in colorectal cancer (CRC) and beyond. Larkx, the company’s proprietary bioinformatics platform, couples machine learning with tumor genetics to discover immune evasion pathways that originate in the tumor and enrich clinical strategies for potential responders to its therapies across multiple types of cancer. The company was founded by Nathanael S. Gray, Vijay Kumar Kuchroo, and Lewis Clayton Cantley. The CEO is Catherine Sabatos-Peyton.